CRP and hepatocellular carcinoma: In fact, emerging evidence has demonstrated the prognostic value of systemic inflammation and immune markers, including neutrophil (6, 7), lymphocyte (8), platelet (9), and C-reactive protein (CRP) (10, 11), in various cancers including HCC.